Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105090406 | 10509040 | 6 | F | 2014 | 20160324 | 20141009 | 20160331 | EXP | US-ASTRAZENECA-2014SE69488 | ASTRAZENECA | 65.00 | YR | F | Y | 51.70000 | KG | 20160331 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105090406 | 10509040 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 320 MCG, TWO TIMES A DAY | U | 21929 | BID | ||||||||
105090406 | 10509040 | 2 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 320 MCG, TWO TIMES A DAY | U | 21929 | BID | ||||||||
105090406 | 10509040 | 3 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, 2 PUFFS TWICE PER DAY | U | 21929 | BID | ||||||||
105090406 | 10509040 | 4 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, 2 PUFFS TWICE PER DAY | U | 21929 | BID | ||||||||
105090406 | 10509040 | 5 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | U | 0 | 400 | UG | INHALATION POWDER | BID | ||||||
105090406 | 10509040 | 6 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | U | 0 | 400 | UG | INHALATION POWDER | BID | ||||||
105090406 | 10509040 | 7 | C | PREVACID | LANSOPRAZOLE | 1 | Oral | 0 | 30 | MG | BID | ||||||||
105090406 | 10509040 | 8 | C | PREVACID | LANSOPRAZOLE | 1 | Oral | 0 | 30 | MG | BID | ||||||||
105090406 | 10509040 | 9 | C | PREVACID | LANSOPRAZOLE | 1 | Oral | 0 | 30 | MG | QD | ||||||||
105090406 | 10509040 | 10 | C | PREVACID | LANSOPRAZOLE | 1 | Oral | 0 | 30 | MG | QD | ||||||||
105090406 | 10509040 | 11 | C | ZETIA | EZETIMIBE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
105090406 | 10509040 | 12 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | Oral | 0 | 240 | MG | QD | ||||||||
105090406 | 10509040 | 13 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 0 | 1 | MG | TID | ||||||||
105090406 | 10509040 | 14 | C | ADDARALL | 2 | Oral | 0 | 15 | MG | QD | |||||||||
105090406 | 10509040 | 15 | C | SELENIUM | SELENIUM | 1 | Oral | 0 | |||||||||||
105090406 | 10509040 | 16 | C | FISH OIL | FISH OIL | 1 | Oral | 0 | |||||||||||
105090406 | 10509040 | 17 | C | OSCAL | CALCIUM CARBONATE | 1 | Oral | 0 | 500 | MG | |||||||||
105090406 | 10509040 | 18 | C | ZOCOR | SIMVASTATIN | 1 | 0 | ||||||||||||
105090406 | 10509040 | 19 | C | PROVENTIL | ALBUTEROL | 1 | 0 | ||||||||||||
105090406 | 10509040 | 20 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | AS REQUIRED | 0 | ||||||||||
105090406 | 10509040 | 21 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
105090406 | 10509040 | 22 | C | AFRIN | OXYMETAZOLINE | 1 | Nasal | AS REQUIRED | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
105090406 | 10509040 | 1 | Chronic obstructive pulmonary disease |
105090406 | 10509040 | 2 | Asthma |
105090406 | 10509040 | 3 | Chronic obstructive pulmonary disease |
105090406 | 10509040 | 4 | Asthma |
105090406 | 10509040 | 5 | Chronic obstructive pulmonary disease |
105090406 | 10509040 | 6 | Asthma |
105090406 | 10509040 | 7 | Ulcer |
105090406 | 10509040 | 8 | Gastrooesophageal reflux disease |
105090406 | 10509040 | 9 | Ulcer |
105090406 | 10509040 | 10 | Gastrooesophageal reflux disease |
105090406 | 10509040 | 11 | Blood cholesterol abnormal |
105090406 | 10509040 | 12 | Dizziness |
105090406 | 10509040 | 13 | Anxiety |
105090406 | 10509040 | 14 | Attention deficit/hyperactivity disorder |
105090406 | 10509040 | 15 | Liver disorder |
105090406 | 10509040 | 17 | Mineral supplementation |
105090406 | 10509040 | 19 | Unevaluable event |
105090406 | 10509040 | 20 | Drug hypersensitivity |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
105090406 | 10509040 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
105090406 | 10509040 | Alveolar osteitis | |
105090406 | 10509040 | Back injury | |
105090406 | 10509040 | Candida infection | |
105090406 | 10509040 | Cataract | |
105090406 | 10509040 | Dysphonia | |
105090406 | 10509040 | Dyspnoea | |
105090406 | 10509040 | Fall | |
105090406 | 10509040 | Fatigue | |
105090406 | 10509040 | Gastrooesophageal reflux disease | |
105090406 | 10509040 | Hot flush | |
105090406 | 10509040 | Hypersomnia | |
105090406 | 10509040 | Intentional device misuse | |
105090406 | 10509040 | Intentional product misuse | |
105090406 | 10509040 | Lymphadenopathy | |
105090406 | 10509040 | Malaise | |
105090406 | 10509040 | Muscle strain | |
105090406 | 10509040 | Pain | |
105090406 | 10509040 | Pain in extremity | |
105090406 | 10509040 | Panic attack | |
105090406 | 10509040 | Productive cough | |
105090406 | 10509040 | Sinus disorder | |
105090406 | 10509040 | Stress | |
105090406 | 10509040 | Viral infection | |
105090406 | 10509040 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
105090406 | 10509040 | 1 | 2012 | 201410 | 0 | |
105090406 | 10509040 | 2 | 2012 | 201410 | 0 | |
105090406 | 10509040 | 11 | 2004 | 0 | ||
105090406 | 10509040 | 12 | 2007 | 0 | ||
105090406 | 10509040 | 13 | 2012 | 0 | ||
105090406 | 10509040 | 14 | 2013 | 0 |